Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Save the Date…. MedCity Investment Hub Showcases for 2021/22.

Thursday, 01 July 2021 to Thursday, 10 February 2022

On 1st of July 2021, 4th of November 2021 and 10th of February 2022 from 3-6.30pm, up to six early-stage companies having a direct or indirect impact on patients will be presenting their business and products.

Industry Insight Seminar Series - Turning Translational Academic Research into Medicines for Patients with Genetic Diseases

Anna Hakes PhD, BridgeBio


Tuesday, 01 February 2022, 12pm to 1.30pm

BridgeBio is a pharmaceutical company that finds, develops and delivers breakthrough medicines for genetic diseases.

BioSeed 2022

In Person

Friday, 25 February 2022, 8am to 7.30pm

BioSeed, which is organised by OBN​, is a fast-paced, one-day pitching event where innovative early-stage Life Sciences companies seeking Seed or Series-A funding, showcase to and meet with an extensive audience of active life sciences investors.

Industry Insight Seminar Series - Combining robotics and AI: the emergence of data-driven drug discovery

Martin-Immanuel Bittner MD DPhil FRSA, Co-Founder & CEO, Arctoris


Tuesday, 01 March 2022, 12pm to 1pm

Arctoris developed Ulysses, a unique platform that brings together robotics, AI, and blockchain to generate data of unprecedented quality, depth and context, at scale.

Industry Insight Seminar Series - Gene Therapy Coming of Age

Yatish Lad, Vice President, Head of Early Development, Oxford Biomedica


Tuesday, 05 April 2022, 12pm to 1pm

Oxford Biomedica is a leading, fully integrated, cell and gene therapy group.